Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Brincidofovir bulk supplier for pharma manufacturers

Brincidofovir 100 mg, 10 mg/ml Suppliers & Bulk Manufacturers

Available Forms: Tablets / Oral suspension

Available Strengths: 100 mg, 10 mg/ml

Reference Brands: Tembexa (USA/EU)

Category: Anti Viral

Brincidofovir is a Anti Viral product available as Tablets / Oral suspension in strengths 100 mg, 10 mg/ml. It corresponds to the reference brand Tembexa (USA/EU). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Brincidofovir is an oral antiviral medication and a lipid-conjugated prodrug of cidofovir designed to improve bioavailability and reduce toxicity compared to intravenous cidofovir. It is composed of cidofovir linked through its phosphonate group to a lipid, 3-hexadecyloxy-1-propanol, which facilitates efficient absorption through the intestinal wall and penetration into virus-infected cells.

Once inside target cells, brincidofovir is cleaved to release cidofovir, which is then phosphorylated by cellular enzymes to form the active metabolite, cidofovir diphosphate. This active form mimics natural nucleotides and competes with deoxycytosine-5-triphosphate (dCTP) for incorporation into viral DNA by viral DNA polymerase. Incorporation of cidofovir diphosphate into the viral DNA disrupts DNA polymerization, halts viral replication, and ultimately inhibits the proliferation of double-stranded DNA viruses.

Compared to traditional cidofovir therapy, brincidofovir offers enhanced oral bioavailability, improved cellular uptake, and reduced systemic toxicity, making it a more convenient and effective option for managing infections caused by a range of DNA viruses.

Brincidofovir — third party manufacturing & bulk supply

Brincidofovir 100 mg, 10 mg/ml is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Brincidofovir listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Brincidofovir →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Brincidofovir is used to treat and prevent DNA virus infections, including cytomegalovirus (CMV) infections in immunocompromised patients.

Brincidofovir is a lipid conjugate of cidofovir designed to inhibit viral DNA polymerase and prevent viral replication with reduced nephrotoxicity.

The trade name of brincidofovir is Tembexa.

Tembexa is developed and marketed by Chimerix, Inc.

The generic name is brincidofovir.

The brand name is Tembexa.

Brincidofovir tablets are manufactured in GMP-certified facilities by Chimerix or its authorized manufacturing partners for global distribution.

Related Products

Cobicistat

Strength:
150 mg

Form: Tablets

Reference Brands: Tybost (USA/EU)

View Details
Lenacapavir

Strength:
300 mg, 463.5 mg/1.5 mL

Form: Tablet / Injection

Reference Brands: Yeztugo (USA), Sunlenca (USA)

View Details
Fostemsavir

Strength:
600 mg

Form: Tablets

Reference Brands: Rukobia (USA)

View Details
Rimantadine Hydrochloride

Strength:
100 mg, 10 mg/mL

Form: Tablet / Syrup

Reference Brands: Flumadine (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.